Las Vegas, NV -- (SBWIRE) -- 01/21/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: North American Palladium Ltd (USA)(NYSEMKT:PAL), National Bank of Greece (ADR)(NYSE:NBG), New Gold Inc. (USA)(NYSEMKT:NGD), Pacific Biosciences of California(NASDAQ:PACB)
North American Palladium Ltd (USA)(NYSEMKT:PAL) was a volume gainer of 2.77 million shares and the average volume of the stock remained 4.03 million shares. The stock opened the session at $0.56 and finished at the end of the day at $0.557 and the stock plunged -0.50%.The market capitalization of the stock remained 109.83 million. North American Palladium Ltd. produces precious metals in Canada. It explores for palladium, platinum, nickel, gold, copper, and other metals. North American Palladium Ltd. was founded in 1968 and is headquartered in Toronto, Canada.
Has PAL Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, National Bank of Greece (ADR)(NYSE:NBG) exchanged 2.77 million shares and the average volume remained 2.92 million shares. The stock closed the session at $5.56 with the drop of -1.94%. National Bank of Greece S.A., together with its subsidiaries, offers diversified financial services primarily in Greece. It serves individuals, professionals, small-medium and small sized companies, and corporate customers.
Why Should Investors Buy NBG After the Recent Fall? Just Go Here and Find Out
New Gold Inc. (USA)(NYSEMKT:NGD) enhanced 1.75% and its closing price was $5.81. The volume of the stock was 2.71 million shares and the average volume remained 3.55 million shares. The market capitalization of the stock remained 2.93 billion. The beta of the stock remained 0.04. New Gold Inc., a gold mining company, engages in the acquisition, exploration, extraction, processing, and reclamation of mineral properties. It primarily explores for gold, silver, and copper deposits.
Why Should Investors Buy NGD After The Recent Gain? Just Go Here and Find Out
Pacific Biosciences of California(NASDAQ:PACB) exchanged 2.71 million shares in the previous trading session, and its average trading remained 774,635.00 shares. PACB advanced 14.44% and it closed the trading at $6.50. The market capitalization of the stock remained 429.99 million. Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes.
For How Long PACB’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)